Nasus Pharma Ltd.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $717.0K
Liabilities Breakdown FY2024
Total Liabilities: $3.9M
Asset Breakdown
Total Assets: $717.0K
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $284.0K | 39.6% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $433.0K | 60.4% |
Liabilities Breakdown
Total Liabilities: $3.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $651.0K | 16.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $3.3M | 83.4% |